Aldo-Keto Reductases and Cancer Drug Resistance is a research paper published in Pharmacological Reviews (2021). On theSindex it has a DataRank of 0. It has been cited 139 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA226436
NIEHS NIH HHS
Grant: R01 ES029294
NIEHS NIH HHS
Grant: P30 ES013508
National Institutes of Health
Grant: 7R01CA226436-02
AKR1C3 Inhibitors as Chemotherapeutic Potentiators
National Institutes of Health
Grant: 5P30ES013508-04
CORE--Endocrine and Reproduction Disruption
National Institutes of Health
Grant: 1R01ES029294-01A1
Metabolic activation of nitroarenes and Nrf2-Keap1
FWCI
9.23
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea
Additional file 1 of Air pollution and survival in patients with malignant mesothelioma and asbestos-related lung cancer: a follow-up study of 1591 patients in South Korea